九种用于预测心血管疾病的胰岛素耐药替代品的比较:一项队列研究
Haoqi Zhou1, Yu Shi2, Xiaohua Zhou3,4
1Department of Biostatistics, School of Public Health, Peking University, 38 Xueyuan Rd, Haidian District, Beijing, 100191, China.
Diabetology & metabolic syndrome
|August 31, 2025
概括
在中国成年人的9个胰岛素抵抗指标中,甘油三糖 (TyG) 指数最能预测心血管疾病 (CVD) 风险. 这种简单的措施为早期心脏病风险评估提供了强有力的工具.
科学领域:
- 心脏病学
- 代谢综合征研究
- 公共卫生
背景情况:
- 胰岛素抵抗 (IR) 是已知的心血管疾病 (CVD) 的风险因素.
- 存在几种简单的IR指标,但它们对预测心血管疾病的比较能力尚未得到充分证实.
- 本研究研究了9个IR替代指标对中国人群中发生的心血管疾病的预测效用.
研究的目的:
- 评估九个IR替代指标和发生的心血管疾病之间的关联.
- 通过比较评估这些IR替代品对心血管疾病的预测能力.
- 确定在中国成年人中早期预测心脏病风险的最有效的IR替代品.
主要方法:
- 在中国健康与退休长度研究 (CHARLS) 中使用了7662名没有心血管疾病的参与者的数据.
- 计算了九个IR替代指标:甘油三指数 (TyG),TG/HDL比,METS-IR,CVAI,LAP,AIP,TyG-BMI,TyG-WC和TyG-WHtR.
- 使用Cox和受限制的立方线模型来分析关系,并使用C指数来比较在8.2年后续的预测性表现.
主要成果:
- 所有9个IR指标都与心血管疾病风险的增加有显著关联.
- 三甘油糖 (TyG) 指数显示出最高的预测性能,C指数为0. 742.
- 在随访期间,该研究观察到1906例心血管病例.
结论:
- 在九种评估的替代品中,甘油三糖 (TyG) 指数是预测中年和老年人心血管疾病的最有效指标.
- TyG指数是早期心血管疾病风险分层的简单,有效和临床可用的工具.
- 这些发现支持TyG指数对主动心血管健康管理的临床实用性.
相关概念视频
Heart Failure Drugs: Inotropic Agents
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure Drugs: β-Blockers
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...


